Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Plerixafor may help restore skin pigmentation safely.

Lanadelumab greatly reduces hospital visits and angioedema episodes, improving life quality for hereditary angioedema patients.

Using a combination of AMD3100 and FK506 can speed up and improve wound healing in diabetic rats.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

SRD5A2 methylation in blood can predict how well someone will respond to finasteride treatment.

Baricitinib effectively treats certain skin conditions but may have serious side effects.

Cyclophosphamide effectively induces cashmere shedding in goats without affecting their overall health.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Antihepcidin antibodies may treat inflammation-induced anemia by improving iron metabolism.

Cyclosporine-A can cause excessive hair growth, which usually stops after discontinuing the drug.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

Targeting NCoR1 can help treat heart enlargement and dysfunction.

PRO-C22 can help diagnose and monitor the severity of hidradenitis suppurativa.

Baricitinib shows promise for treating alopecia areata with mild side effects.

The new ELISA method is reliable and eco-friendly for checking the quality of Pueraria candollei.

Caribine from traditional Chinese medicine may help treat hair loss.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

c-Kit is important for heart regeneration and cancer development.